Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 89

1.

Synergy between tobramycin and trivalent chromium ion in electrochemical control of Pseudomonas aeruginosa.

Niepa TH, Wang H, Dabrowiak JC, Gilbert JL, Ren D.

Acta Biomater. 2016 May;36:286-95. doi: 10.1016/j.actbio.2016.03.028. Epub 2016 Mar 17.

PMID:
26996376
2.

Multifunctional DNA-gold nanoparticles for targeted doxorubicin delivery.

Alexander CM, Hamner KL, Maye MM, Dabrowiak JC.

Bioconjug Chem. 2014 Jul 16;25(7):1261-71. doi: 10.1021/bc500136r. Epub 2014 Jun 19.

PMID:
24911830
3.

Cyclodextrin capped gold nanoparticles as a delivery vehicle for a prodrug of cisplatin.

Shi Y, Goodisman J, Dabrowiak JC.

Inorg Chem. 2013 Aug 19;52(16):9418-26. doi: 10.1021/ic400989v. Epub 2013 Jul 29.

PMID:
23889547
4.

Gravitational sedimentation of gold nanoparticles.

Alexander CM, Dabrowiak JC, Goodisman J.

J Colloid Interface Sci. 2013 Apr 15;396:53-62. doi: 10.1016/j.jcis.2013.01.005. Epub 2013 Jan 23.

PMID:
23403117
5.

Investigation of the drug binding properties and cytotoxicity of DNA-capped nanoparticles designed as delivery vehicles for the anticancer agents doxorubicin and actinomycin D.

Alexander CM, Dabrowiak JC, Maye MM.

Bioconjug Chem. 2012 Oct 17;23(10):2061-70. doi: 10.1021/bc3002634. Epub 2012 Oct 8.

PMID:
23043330
6.

Enhanced detection of gold nanoparticles in agarose gel electrophoresis.

Hasenoehrl C, Alexander CM, Azzarelli NN, Dabrowiak JC.

Electrophoresis. 2012 Apr;33(8):1251-4. doi: 10.1002/elps.201100556.

PMID:
22589102
7.

Pt(IV) complexes as prodrugs for cisplatin.

Shi Y, Liu SA, Kerwood DJ, Goodisman J, Dabrowiak JC.

J Inorg Biochem. 2012 Feb;107(1):6-14. doi: 10.1016/j.jinorgbio.2011.10.012. Epub 2011 Nov 3.

PMID:
22169035
8.

Adamantane-platinum conjugate hosted in β-cyclodextrin: enhancing transport and cytotoxicity by noncovalent modification.

Prashar D, Shi Y, Bandyopadhyay D, Dabrowiak JC, Luk YY.

Bioorg Med Chem Lett. 2011 Dec 15;21(24):7421-5. doi: 10.1016/j.bmcl.2011.10.006. Epub 2011 Oct 14.

PMID:
22050886
9.

Stability of carboplatin and oxaliplatin in their infusion solutions is due to self-association.

Di Pasqua AJ, Kerwood DJ, Shi Y, Goodisman J, Dabrowiak JC.

Dalton Trans. 2011 May 14;40(18):4821-5. doi: 10.1039/c0dt01758b. Epub 2011 Apr 4.

PMID:
21461444
10.

DNA-capped nanoparticles designed for doxorubicin drug delivery.

Alexander CM, Maye MM, Dabrowiak JC.

Chem Commun (Camb). 2011 Mar 28;47(12):3418-20. doi: 10.1039/c0cc04916f. Epub 2011 Feb 1.

PMID:
21286626
11.

Cytotoxicity of Cu(II) and Zn(II) 2,2'-bipyridyl complexes: dependence of IC50 on recovery time.

Shi Y, Toms BB, Dixit N, Kumari N, Mishra L, Goodisman J, Dabrowiak JC.

Chem Res Toxicol. 2010 Aug 16;23(8):1417-26. doi: 10.1021/tx100126f.

PMID:
20672868
12.

Adsorption of the Pt(II) anticancer drug carboplatin by mesoporous silica.

Di Pasqua AJ, Wallner S, Kerwood DJ, Dabrowiak JC.

Chem Biodivers. 2009 Sep;6(9):1343-9. doi: 10.1002/cbdv.200900021.

PMID:
19774597
13.

Formation of carbonato and hydroxo complexes in the reaction of platinum anticancer drugs with carbonate.

Di Pasqua AJ, Centerwall CR, Kerwood DJ, Dabrowiak JC.

Inorg Chem. 2009 Feb 2;48(3):1192-7. doi: 10.1021/ic801579h.

PMID:
19113934
14.

Influence of carbonate on the binding of carboplatin to DNA.

Sorokanich RS, Di Pasqua AJ, Geier M, Dabrowiak JC.

Chem Biodivers. 2008 Aug;5(8):1540-4. doi: 10.1002/cbdv.200890142.

PMID:
18729090
15.

New extracellular resistance mechanism for cisplatin.

Centerwall CR, Kerwood DJ, Goodisman J, Toms BB, Dabrowiak JC.

J Inorg Biochem. 2008 May-Jun;102(5-6):1044-9. doi: 10.1016/j.jinorgbio.2008.01.008. Epub 2008 Jan 16.

PMID:
18294693
16.

Cytotoxicity of mesoporous silica nanomaterials.

Di Pasqua AJ, Sharma KK, Shi YL, Toms BB, Ouellette W, Dabrowiak JC, Asefa T.

J Inorg Biochem. 2008 Jul;102(7):1416-23. doi: 10.1016/j.jinorgbio.2007.12.028. Epub 2008 Jan 9.

PMID:
18279965
17.

Modification of carboplatin by Jurkat cells.

Di Pasqua AJ, Goodisman J, Kerwood DJ, Toms BB, Dabrowiak JC.

J Inorg Biochem. 2007 Oct;101(10):1438-41. Epub 2007 Jun 21.

PMID:
17655933
18.

The activation of platinum(II) antiproliferative drugs in carbonate medium evaluated by means of a DNA-biosensor.

Ravera M, Bagni G, Mascini M, Dabrowiak JC, Osella D.

J Inorg Biochem. 2007 Jul;101(7):1023-7. Epub 2007 Apr 19.

PMID:
17524484
19.

Role of carbonate in the cytotoxicity of carboplatin.

Di Pasqua AJ, Goodisman J, Kerwood DJ, Toms BB, Dubowy RL, Dabrowiak JC.

Chem Res Toxicol. 2007 Jun;20(6):896-904. Epub 2007 May 12.

PMID:
17497898
20.

Modification and uptake of a cisplatin carbonato complex by Jurkat cells.

Centerwall CR, Tacka KA, Kerwood DJ, Goodisman J, Toms BB, Dubowy RL, Dabrowiak JC.

Mol Pharmacol. 2006 Jul;70(1):348-55. Epub 2006 Apr 21.

PMID:
16632646
21.

Formation of monofunctional cisplatin-DNA adducts in carbonate buffer.

Binter A, Goodisman J, Dabrowiak JC.

J Inorg Biochem. 2006 Jul;100(7):1219-24. Epub 2006 Mar 20.

PMID:
16545458
22.

Activation of carboplatin by carbonate.

Di Pasqua AJ, Goodisman J, Kerwood DJ, Toms BB, Dubowy RL, Dabrowiak JC.

Chem Res Toxicol. 2006 Jan;19(1):139-49.

PMID:
16411667
23.

Cisplatin carbonato complexes. Implications for uptake, antitumor properties, and toxicity.

Centerwall CR, Goodisman J, Kerwood DJ, Dabrowiak JC.

J Am Chem Soc. 2005 Sep 21;127(37):12768-9.

PMID:
16159248
24.

Experimental and theoretical studies on the pharmacodynamics of cisplatin in jurkat cells.

Tacka KA, Szalda D, Souid AK, Goodisman J, Dabrowiak JC.

Chem Res Toxicol. 2004 Nov;17(11):1434-44.

PMID:
15540941
25.

Effects of cisplatin on mitochondrial function in Jurkat cells.

Tacka KA, Dabrowiak JC, Goodisman J, Penefsky HS, Souid AK.

Chem Res Toxicol. 2004 Aug;17(8):1102-11. Erratum in: Chem Res Toxicol. 2004 Sep;17(9):1297.

PMID:
15310242
26.

Specificity of neomycin analogues bound to the packaging region of human immunodeficiency virus type 1 RNA.

McPike MP, Goodisman J, Dabrowiak JC.

Bioorg Med Chem. 2004 Apr 15;12(8):1835-43.

PMID:
15051052
27.

Kinetic study on the reaction of cisplatin with metallothionein.

Hagrman D, Goodisman J, Dabrowiak JC, Souid AK.

Drug Metab Dispos. 2003 Jul;31(7):916-23.

PMID:
12814969
28.

Kinetic study of the reaction of cisplatin with thiols.

Dabrowiak JC, Goodisman J, Souid AK.

Drug Metab Dispos. 2002 Dec;30(12):1378-84.

PMID:
12433807
29.
30.

Kinetic analysis of the reactions of 4-hydroperoxycyclophosphamide and acrolein with glutathione, mesna, and WR-1065.

Tacka KA, Dabrowiak JC, Goodisman J, Souid AK.

Drug Metab Dispos. 2002 Aug;30(8):875-82.

PMID:
12124304
31.
32.

Absorption studies on aminoglycoside binding to the packaging region of human immunodeficiency virus type-1.

Sullivan JM, Goodisman J, Dabrowiak JC.

Bioorg Med Chem Lett. 2002 Feb 25;12(4):615-8.

PMID:
11844684
33.

Kinetics of cisplatin binding to cellular DNA and modulations by thiol-blocking agents and thiol drugs.

Sadowitz PD, Hubbard BA, Dabrowiak JC, Goodisman J, Tacka KA, Aktas MK, Cunningham MJ, Dubowy RL, Souid AK.

Drug Metab Dispos. 2002 Feb;30(2):183-90.

PMID:
11792689
34.

Drug-RNA footprinting.

McPike MP, Goodisman J, Dabrowiak JC.

Methods Enzymol. 2001;340:431-49.

PMID:
11494862
35.

Characterization of hairpin-duplex interconversion of DNA using polyacrylamide gel electrophoresis.

Shubsda M, Goodisman J, Dabrowiak JC.

Biophys Chem. 1999 Feb 1;76(2):95-115. No abstract available.

PMID:
11396505
36.

Binding of human immunodeficiency virus type 1 nucleocapsid protein to psi-RNA-SL3.

Shubsda MF, Kirk CA, Goodisman J, Dabrowiak JC.

Biophys Chem. 2000 Oct 30;87(2-3):149-65.

PMID:
11099178
37.

Monomer-dimer equilibrium constants of RNA in the dimer initiation site of human immunodeficiency virus type 1.

Shubsda MF, McPike MP, Goodisman J, Dabrowiak JC.

Biochemistry. 1999 Aug 3;38(31):10147-57.

PMID:
10433723
38.

Kinetic analysis of drug cleavage of closed-circular DNA.

Goodisman J, Kirk C, Dabrowiak JC.

Biophys Chem. 1997 Dec 1;69(2-3):249-68.

PMID:
9474758
39.

Quantitation of ethidium-stained closed circular DNA in agarose gels.

Shubsda MF, Goodisman J, Dabrowiak JC.

J Biochem Biophys Methods. 1997 Feb 1;34(1):73-9.

PMID:
9089386
40.

Kinetics of cleavage of intra- and extracellular simian virus 40 DNA with the enediyne anticancer drug C-1027.

Kirk CA, Goodisman J, Beerman TA, Gawron LS, Dabrowiak JC.

Biophys Chem. 1997 Jan 31;63(2-3):201-9.

PMID:
9108692
41.

Quantitative DNA footprinting.

Dabrowiak JC, Goodisman J, Ward B.

Methods Mol Biol. 1997;90:23-42. Review. No abstract available.

PMID:
9407525
42.

Cleavage of DNA by the insulin-mimetic compound, NH4[VO(O2)2(phen)].

Hiort C, Goodisman J, Dabrowiak JC.

Biochemistry. 1996 Sep 24;35(38):12354-62.

PMID:
8823170
43.

Chemically and photochemically initiated DNA cleavage by an insulin-mimetic bisperoxovanadium complex.

Hiort C, Goodisman J, Dabrowiak JC.

Mol Cell Biochem. 1995 Dec 6-20;153(1-2):31-6.

PMID:
8927045
44.

PCR generation of large amounts of purified DNA.

Falzon L, Kirk C, Chaires JB, Dabrowiak JC.

J Biochem Biophys Methods. 1994 Dec;29(3-4):251-7.

PMID:
7699202
45.

Cleavage of tubulin by vanadate ion.

Correia JJ, Lipscomb LD, Dabrowiak JC, Isern N, Zubieta J.

Arch Biochem Biophys. 1994 Feb 15;309(1):94-104.

PMID:
8117118
46.

Interaction of cationic porphyrins with DNA.

Sehlstedt U, Kim SK, Carter P, Goodisman J, Vollano JF, Nordén B, Dabrowiak JC.

Biochemistry. 1994 Jan 18;33(2):417-26.

PMID:
8286372
47.

Tris(phenanthroline)ruthenium(II) enantiomer interactions with DNA: mode and specificity of binding.

Satyanarayana S, Dabrowiak JC, Chaires JB.

Biochemistry. 1993 Mar 16;32(10):2573-84.

PMID:
8448115
48.

Neither delta- nor lambda-tris(phenanthroline)ruthenium(II) binds to DNA by classical intercalation.

Satyanarayana S, Dabrowiak JC, Chaires JB.

Biochemistry. 1992 Oct 6;31(39):9319-24.

PMID:
1390718
49.

Quantitative footprinting analysis of the chromomycin A3--DNA interaction.

Stankus A, Goodisman J, Dabrowiak JC.

Biochemistry. 1992 Sep 29;31(38):9310-8.

PMID:
1390717
50.

Structural changes and enhancements in DNase I footprinting experiments.

Goodisman J, Dabrowiak JC.

Biochemistry. 1992 Feb 4;31(4):1058-64.

PMID:
1734955

Supplemental Content

Loading ...
Support Center